Related Experiment Video
Updated: Apr 30, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Altered serine/threonine kinase activity in schizophrenia
Jennifer L McGuire1, John H Hammond2, Stefani D Yates2
1Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.
Schizophrenia involves altered signaling pathways. A new kinase array platform revealed widespread changes in protein kinase activity in the brain, offering new drug targets for this psychiatric disorder.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Schizophrenia etiology involves multiple signaling pathway alterations.
- Previous studies were limited to analyzing few phosphoproteins.
- Simultaneous analysis of signaling cascades is needed.
Purpose of the Study:
- To simultaneously investigate multiple signaling cascades in schizophrenia.
- To identify differentially phosphorylated peptide substrates in the frontal cortex.
- To explore potential drug targets for schizophrenia treatment.
Main Methods:
- Utilized a novel kinase array platform to assess >100 serine/threonine protein kinase activities.
- Analyzed frontal cortex tissue from schizophrenia patients.
- Employed Ingenuity Pathway Analysis (IPA) for functional grouping of phosphopeptides.
Main Results:
- Identified 19 differentially phosphorylated peptide substrates (>15% change) in the frontal cortex.
- Pathway analysis revealed involvement in cellular homeostasis (14 peptides), cytoskeletal organization (10 peptides), and ion homeostasis (8 peptides).
- This is the first study to comprehensively investigate signaling cascade changes in schizophrenia.
Conclusions:
- Comprehensive analysis of kinase activity provides novel insights into schizophrenia pathophysiology.
- Findings highlight the role of cellular homeostasis, cytoskeletal, and ion homeostasis pathways.
- This approach may facilitate the discovery of new drug targets for schizophrenia treatment.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Psychosis and Antipsychotic Drugs: Overview
Psychological and Sociocultural Causes of Schizophrenia

